Sage Journals: Discover world-class research

Retricted access

Review article

First published 2019-10

The emergence of follow-on disease-modifying therapies for multiple sclerosis

Brandon P Moss, Jeffrey A Cohen

Multiple Sclerosis Journal

Open access

Review article

First published 2021

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

Heinz Wiendl, Ralf Gold, Thomas Berger [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2018-7

The effect of disease modifying therapies on CD62L expression in multiple sclerosis

Margarete Maria Voortman, Paul Greiner, Daniel Moser [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Review article

First published 2021

Health economics of disease-modifying therapy for multiple sclerosis in the United States

Daniel M. Hartung

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2020-10

Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies

Marisa P McGinley, Philip A Cola, Robert J Fox [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2016

Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice

Erin E Longbrake, Anne H Cross, Amber Salter

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2021

Disease-modifying therapy prescription patterns in people with multiple sclerosis by age

Yinan Zhang, Amber Salter, Shan Jin [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2013-6

Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis

Bruce AC Cree

Multiple Sclerosis Journal

Retricted access

Other

First published 2009-12

Discontinuing disease-modifying therapy in progressive multiple sclerosis: can we stop what we have started?

Roisín Lonergan, Katie Kinsella, Marguerite Duggan [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2021

Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis

Gisela Zanga, Estefania Drzewiscki, Paula Tagliani [...]

Therapeutic Advances in Neurological Disorders

Search results